Keywords: aventis, chugai, end, taxotere, deal, pharma, japan
Aventis and Chugai to end Taxotere deal
Article | 08 August 2000
Aventis Pharma in Japan and Chugai Pharmaceutical have terminated theirdeal - established in 1992 - for the co-development and co-distribution of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
